Patients with a history of gastrointestinal issues including gastritis, acid reflux treated with PPIs, or any condition affecting stomach lining integrity already have compromised B12 absorption pathways
Pancreatic alpha-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation
Improved gut health leads to better long-term metabolic balance, making it easier to maintain weight loss
But these probably shouldnt be a long-term option
Tips for Taking a Break from GLP-1 Medication To make taking a break as smooth as possible, Zeinab offers these practical tips: Be Comfortable and Dont Over-worry: Its natural to be concerned about potential weight fluctuations, but try to relax and enjoy your time off
The pharmaceutical company Eli Lilly, which is developing Retatrutide, has not announced an exact timeline for completion, but most industry observers expect results to be available sometime in 2025 or early 2026